Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Kirchmeier

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|July 24, 2010
Monoclonal antibody aggregation intermediates visualized by atomic force microscopyHanjoo Lee, Marc Kirchmeier, Henryk Mach
Journal of Pharmaceutical Sciences|August 28, 2007
Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodiesRoxana M Ionescu, Josef Vlasak, Colleen Price, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 17, 2017
Development of a solid dosage platform for the oral delivery of bilayer vesiclesJitinder S Wilkhu, Sarah E McNeil, David E Anderson, et al.
Therapeutic Delivery|July 24, 2012
Electrostatic interactions of monoclonal antibodies with subcutaneous tissueHenryk Mach, Sonia M Gregory, Alexis Mackiewicz, et al.
Analytical Biochemistry|June 6, 2009
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibodyJosef Vlasak, Marie C Bussat, Shiyi Wang, et al.
Clinical and Vaccine Immunology : CVI|December 17, 2013
Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activityMarc Kirchmeier, Anne-Catherine Fluckiger, Catalina Soare, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|July 24, 2010
Monoclonal antibody aggregation intermediates visualized by atomic force microscopyHanjoo Lee, Marc Kirchmeier, Henryk Mach
Journal of Pharmaceutical Sciences|August 28, 2007
Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodiesRoxana M Ionescu, Josef Vlasak, Colleen Price, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 17, 2017
Development of a solid dosage platform for the oral delivery of bilayer vesiclesJitinder S Wilkhu, Sarah E McNeil, David E Anderson, et al.
Therapeutic Delivery|July 24, 2012
Electrostatic interactions of monoclonal antibodies with subcutaneous tissueHenryk Mach, Sonia M Gregory, Alexis Mackiewicz, et al.
Analytical Biochemistry|June 6, 2009
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibodyJosef Vlasak, Marie C Bussat, Shiyi Wang, et al.
Clinical and Vaccine Immunology : CVI|December 17, 2013
Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activityMarc Kirchmeier, Anne-Catherine Fluckiger, Catalina Soare, et al.
Pageof 1